Torti Frank — SEC insider filings

SEC reporting owner CIK 1647805. 20 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2021-03-23 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Roivant Sciences Ltd. (ROIV)President and Vant Chair7—3 legs · 3,000,000 sh · $82,039,46021
Immunovant, Inc. (IMVT)Director81 leg · 20,000 sh · $116,200—14
Arbutus Biopharma Corp (ABUS)Director4——4
Sio Gene Therapies Inc. (SIOX)Director1——1

Insider filings — Torti Frank

FiledFormIssuerReported transactionsSource
2026-11-124Roivant Sciences Ltd. (ROIV)Other (J): 173,683 @ $40.43 · Other (J): 218,369 @ $41.13 · Other (J): 240,755 @ $41.63 · Other (J): 151,293 @ $42.01 · Other (J): 329,550 @ $40.36 · Other (J): 62,493 @ $41.13 · +1 moreEDGAR
2026-10-024Roivant Sciences Ltd. (ROIV)Tax withholding (F): 40,309 @ $36.57EDGAR
2026-07-024Roivant Sciences Ltd. (ROIV)Tax withholding (F): 40,310 @ $35.39EDGAR
2026-04-094Immunovant, Inc. (IMVT)Grant/award (A): 174,189 @ $0 · Grant/award (A): 88,325 (derivative) @ $0EDGAR
2026-04-024Roivant Sciences Ltd. (ROIV)Tax withholding (F): 160,035 @ $27.70EDGAR
2026-02-234Roivant Sciences Ltd. (ROIV)Option exercise (M): 1,400,000 @ $3.85 · Sale (S): 1,400,000 @ $27.42 · Option exercise (M): 1,012,610 @ $3.85 · Sale (S): 1,012,610 @ $27.15 · Option exercise (M): 587,390 @ $3.85 · Sale (S): 587,390 @ $27.51 · +3 moreEDGAR
2025-12-294Roivant Sciences Ltd. (ROIV)Grant/award (A): 175,380 @ $22.45 · Other (J): 64,891 @ $22.47 · Gift (G): 110,489 @ $0EDGAR
2025-08-014Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,836,547 @ $0 · Grant/award (A): 11,900,000 @ $0EDGAR
2025-04-034Immunovant, Inc. (IMVT)Grant/award (A): 199,365 @ $0 · Grant/award (A): 93,599 (derivative) @ $0EDGAR
2024-05-244Arbutus Biopharma Corp (ABUS)Grant/award (A): 67,000 (derivative) @ $0EDGAR
2024-04-044Immunovant, Inc. (IMVT)Grant/award (A): 120,400 @ $0 · Grant/award (A): 50,167 (derivative) @ $0EDGAR
2023-05-264Arbutus Biopharma Corp (ABUS)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2023-04-144Immunovant, Inc. (IMVT)Grant/award (A): 121,916 @ $0 · Grant/award (A): 158,292 (derivative) @ $0EDGAR
2022-09-294Immunovant, Inc. (IMVT)Purchase (P): 20,000 @ $5.81EDGAR
2022-08-194Immunovant, Inc. (IMVT)Grant/award (A): 225,632 @ $0 · Grant/award (A): 339,296 (derivative) @ $0EDGAR
2022-05-264Arbutus Biopharma Corp (ABUS)Grant/award (A): 41,000 (derivative) @ $0EDGAR
2022-01-124Immunovant, Inc. (IMVT)Grant/award (A): 100,126 @ $0 · Grant/award (A): 329,485 (derivative) @ $0EDGAR
2021-06-074Arbutus Biopharma Corp (ABUS)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2021-04-194Sio Gene Therapies Inc. (SIOX)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2021-03-234Immunovant, Inc. (IMVT)Grant/award (A): 19,200 @ $0 · Grant/award (A): 28,900 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs